West Pharmaceutical Services, I
WST
Jodie read · what matters now
Revenue increased 21.0% versus the comparable filing period.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to WST, and whether its market group begins moving.
Latest filing assessment · baseline
Fundamentals strengthened in the latest filing
10-Q filed 2026-04-23 against the comparable filing from 2025-04-24.
What improved
- Revenue increased 21.0% versus the comparable filing period.
- Operating margin improved 5.6 percentage points.
- Net income increased 54.6% versus the comparable filing period.
What weakened
No thresholded deterioration was identified.
Filing receipts
“West Vantage gross profit margin decreased by 0.6 margin points for the three months ended March 31, 2026, as compared to the same period in 2025, due primarily to increased production costs, partially offset by sales price increases.”
“Proprietary Products - Proprietary Products operating profit increased by $58.6 million, or 44.9%, for the three months ended March 31, 2026, as compared to the same period in 2025, including a favorable foreign currency translation impa ct of $12.4 million , due to the factors described above, most no tably increased customer demand, primarily of high value components, and sales price increases.”
“West Vantage - West Vantage operating profit increased by $2.1 million , or 15.6%, for the three months ended March 31, 2026, as compared to the same period in 2025, including a favorable foreign currency translation impact of $1.0 million , due to the factors described abov e, most notably sales price increases and foreign exchange gains, partially offset by increased production costs.”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Who this business touches
The relationships behind WST
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
WST is currently a Leader in the organic co-movement group Injectable Drug Delivery. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for WST; it is not active in the latest market snapshot.
Theme membership history
No durable theme membership has been observed for this name yet.